ONCOLOGY EVOLVED WUGEN TECHNOLOGY Latest News Wugen Announces Exclusive License Agreement for their Memory Natural Killer (NK) Cell-based Therapy Program with Washington University in St. Louis February 22, 2021 Press Releases Wugen Appoints Jan Davidson M.D., Ph.D., as Chief Medical Officer to Guide the Company’s Global NK and T cell Clinical Programs February 22, 2021 Press Releases Wugen Ramps Up Off-the-Shelf Gene Therapies to Fight Cancer January 26, 2021 Articles